November 9th, 2010
•Many infections elicit a strong CTL response, but occasionally, the quantity of responding cells does not correlate to control of the pathogen1. One measure of CTL quality is their ability to kill specifically2. CFSE labeling of target cells can be used to investigate this CTL response quality in vivo3,4.
Tags
Related Videos
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
Introducing Shear Stress in the Study of Bacterial Adhesion
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved